Health Catalyst, Inc. HCAT
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -20.15% | -0.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -20.15% | -0.38% | |||
| Cost of Revenue | -8.44% | 0.24% | |||
| Gross Profit | -31.75% | -0.98% | |||
| SG&A Expenses | -3.22% | -9.93% | |||
| Depreciation & Amortization | -11.39% | -9.38% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.66% | -4.19% | |||
| Operating Income | -245.61% | 44.15% | |||
| Income Before Tax | 199.70% | 63.64% | |||
| Income Tax Expenses | -224.76% | -23.91% | |||
| Earnings from Continuing Operations | 199.90% | 63.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 199.90% | 63.49% | |||
| EBIT | -245.61% | 44.15% | |||
| EBITDA | -259.55% | 114.78% | |||
| EPS Basic | 198.01% | 64.16% | |||
| Normalized Basic EPS | -77.17% | 32.23% | |||
| EPS Diluted | 196.70% | 64.16% | |||
| Normalized Diluted EPS | -75.91% | 32.23% | |||
| Average Basic Shares Outstanding | 1.93% | 1.88% | |||
| Average Diluted Shares Outstanding | 2.67% | 1.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||